Cargando…

Pien Tze Huang Overcomes Multidrug Resistance and Epithelial-Mesenchymal Transition in Human Colorectal Carcinoma Cells via Suppression of TGF-β Pathway

The traditional Chinese medicine formula Pien Tze Huang (PZH) has long been used as a folk remedy for cancer. To elucidate the mode of action of PZH against cancer, in the present study we used a 5-FU resistant human colorectal carcinoma cell line (HCT-8/5-FU) to evaluate the effects of PZH on multi...

Descripción completa

Detalles Bibliográficos
Autores principales: Shen, Aling, Chen, Hongwei, Chen, Youqin, Lin, Jiumao, Lin, Wei, Liu, Liya, Sferra, Thomas J., Peng, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4253702/
https://www.ncbi.nlm.nih.gov/pubmed/25505925
http://dx.doi.org/10.1155/2014/679436
_version_ 1782347274977804288
author Shen, Aling
Chen, Hongwei
Chen, Youqin
Lin, Jiumao
Lin, Wei
Liu, Liya
Sferra, Thomas J.
Peng, Jun
author_facet Shen, Aling
Chen, Hongwei
Chen, Youqin
Lin, Jiumao
Lin, Wei
Liu, Liya
Sferra, Thomas J.
Peng, Jun
author_sort Shen, Aling
collection PubMed
description The traditional Chinese medicine formula Pien Tze Huang (PZH) has long been used as a folk remedy for cancer. To elucidate the mode of action of PZH against cancer, in the present study we used a 5-FU resistant human colorectal carcinoma cell line (HCT-8/5-FU) to evaluate the effects of PZH on multidrug resistance (MDR) and epithelial-mesenchymal transition (EMT) as well as the activation of TGF-β pathway. We found that PZH dose-dependently inhibited the viability of HCT-8/5-FU cells which were insensitive to treatment of 5-FU and ADM, demonstrating the ability of PZH to overcome chemoresistance. Furthermore, PZH increased the intercellular accumulation of Rhodamine-123 and downregulated the expression of ABCG2 in HCT-8/5-FU cells. In addition, drug resistance induced the process of EMT in HCT-8 cells as evidenced by EMT-related morphological changes and alteration in the expression of EMT-regulatory factors, which however was neutralized by PZH treatment. Moreover, PZH inhibited MDR/EMT-enhanced migration and invasion capabilities of HCT-8 cells in a dose-dependent manner and suppressed MDR-induced activation of TGF-β signaling in HCT-8/5-FU cells. Taken together, our study suggests that PZH can effectively overcome MDR and inhibit EMT in human colorectal carcinoma cells via suppression of the TGF-β pathway.
format Online
Article
Text
id pubmed-4253702
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-42537022014-12-11 Pien Tze Huang Overcomes Multidrug Resistance and Epithelial-Mesenchymal Transition in Human Colorectal Carcinoma Cells via Suppression of TGF-β Pathway Shen, Aling Chen, Hongwei Chen, Youqin Lin, Jiumao Lin, Wei Liu, Liya Sferra, Thomas J. Peng, Jun Evid Based Complement Alternat Med Research Article The traditional Chinese medicine formula Pien Tze Huang (PZH) has long been used as a folk remedy for cancer. To elucidate the mode of action of PZH against cancer, in the present study we used a 5-FU resistant human colorectal carcinoma cell line (HCT-8/5-FU) to evaluate the effects of PZH on multidrug resistance (MDR) and epithelial-mesenchymal transition (EMT) as well as the activation of TGF-β pathway. We found that PZH dose-dependently inhibited the viability of HCT-8/5-FU cells which were insensitive to treatment of 5-FU and ADM, demonstrating the ability of PZH to overcome chemoresistance. Furthermore, PZH increased the intercellular accumulation of Rhodamine-123 and downregulated the expression of ABCG2 in HCT-8/5-FU cells. In addition, drug resistance induced the process of EMT in HCT-8 cells as evidenced by EMT-related morphological changes and alteration in the expression of EMT-regulatory factors, which however was neutralized by PZH treatment. Moreover, PZH inhibited MDR/EMT-enhanced migration and invasion capabilities of HCT-8 cells in a dose-dependent manner and suppressed MDR-induced activation of TGF-β signaling in HCT-8/5-FU cells. Taken together, our study suggests that PZH can effectively overcome MDR and inhibit EMT in human colorectal carcinoma cells via suppression of the TGF-β pathway. Hindawi Publishing Corporation 2014 2014-11-19 /pmc/articles/PMC4253702/ /pubmed/25505925 http://dx.doi.org/10.1155/2014/679436 Text en Copyright © 2014 Aling Shen et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Shen, Aling
Chen, Hongwei
Chen, Youqin
Lin, Jiumao
Lin, Wei
Liu, Liya
Sferra, Thomas J.
Peng, Jun
Pien Tze Huang Overcomes Multidrug Resistance and Epithelial-Mesenchymal Transition in Human Colorectal Carcinoma Cells via Suppression of TGF-β Pathway
title Pien Tze Huang Overcomes Multidrug Resistance and Epithelial-Mesenchymal Transition in Human Colorectal Carcinoma Cells via Suppression of TGF-β Pathway
title_full Pien Tze Huang Overcomes Multidrug Resistance and Epithelial-Mesenchymal Transition in Human Colorectal Carcinoma Cells via Suppression of TGF-β Pathway
title_fullStr Pien Tze Huang Overcomes Multidrug Resistance and Epithelial-Mesenchymal Transition in Human Colorectal Carcinoma Cells via Suppression of TGF-β Pathway
title_full_unstemmed Pien Tze Huang Overcomes Multidrug Resistance and Epithelial-Mesenchymal Transition in Human Colorectal Carcinoma Cells via Suppression of TGF-β Pathway
title_short Pien Tze Huang Overcomes Multidrug Resistance and Epithelial-Mesenchymal Transition in Human Colorectal Carcinoma Cells via Suppression of TGF-β Pathway
title_sort pien tze huang overcomes multidrug resistance and epithelial-mesenchymal transition in human colorectal carcinoma cells via suppression of tgf-β pathway
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4253702/
https://www.ncbi.nlm.nih.gov/pubmed/25505925
http://dx.doi.org/10.1155/2014/679436
work_keys_str_mv AT shenaling pientzehuangovercomesmultidrugresistanceandepithelialmesenchymaltransitioninhumancolorectalcarcinomacellsviasuppressionoftgfbpathway
AT chenhongwei pientzehuangovercomesmultidrugresistanceandepithelialmesenchymaltransitioninhumancolorectalcarcinomacellsviasuppressionoftgfbpathway
AT chenyouqin pientzehuangovercomesmultidrugresistanceandepithelialmesenchymaltransitioninhumancolorectalcarcinomacellsviasuppressionoftgfbpathway
AT linjiumao pientzehuangovercomesmultidrugresistanceandepithelialmesenchymaltransitioninhumancolorectalcarcinomacellsviasuppressionoftgfbpathway
AT linwei pientzehuangovercomesmultidrugresistanceandepithelialmesenchymaltransitioninhumancolorectalcarcinomacellsviasuppressionoftgfbpathway
AT liuliya pientzehuangovercomesmultidrugresistanceandepithelialmesenchymaltransitioninhumancolorectalcarcinomacellsviasuppressionoftgfbpathway
AT sferrathomasj pientzehuangovercomesmultidrugresistanceandepithelialmesenchymaltransitioninhumancolorectalcarcinomacellsviasuppressionoftgfbpathway
AT pengjun pientzehuangovercomesmultidrugresistanceandepithelialmesenchymaltransitioninhumancolorectalcarcinomacellsviasuppressionoftgfbpathway